Valuation Stories

As we approach the end of the year, investors are keenly watching UFP Industries, a leading player in the Lumber & Wood Production industry, traded on the NASDAQ. The company has shown robust financial health, with a net asset value of $3.67 billion and total revenue reaching an impressive $9.6 billion. UFP Industries' strong cash flow from operations, which stands at $831.57 million, coupled with a net working capital of $1.7 billion, underscores its solid financial footing.
  over three months ago at Macroaxis 
By Ellen Johnson
Ellen Johnson
Biodesix Inc. currently holds $31.85 million in liabilities, with a Debt to Equity (D/E) ratio of 3.2. This suggests that Biodesix Inc. heavily relies on financing its operations through borrowing. The company's current ratio stands at 0.63, indicating a negative working capital, which could potentially lead to difficulties in meeting its financial obligations when they are due.
  over three months ago at Macroaxis 
By Ellen Johnson
Ellen Johnson
Biodesix Inc. (NASDAQ: BDSX), a key player in the Healthcare sector, has shown remarkable resilience in the face of a challenging market environment. Despite a loss of $50.5M in EBIT and a negative profit margin of 1.59%, the company's stock has been climbing steadily. The company's total liabilities stand at $72.3M, with other current liabilities amounting to $18.6M.
  over three months ago at Macroaxis 
By Raphi Shpitalnik
Raphi Shpitalnik
Saratoga Investment Corp, an asset management firm, presents an intriguing investment opportunity from a valuation perspective. With a trailing PE ratio of 11.22, the company is attractively valued compared to the industry average. Furthermore, the company has a robust net asset value of $1.08 billion, showcasing a strong balance sheet.
  over six months ago at Macroaxis 
By Vlad Skutelnik
Vlad Skutelnik
Broadstone Net Lease Inc., a prominent player in the REIT-Diversified industry, is positioned for an impressive performance in November. The company's strong financial health, reflected in its substantial end period cash flow of $60M and total assets worth $5.46B, provides a solid foundation for growth. Broadstone's trailing PE of 18.22 and a book value of 16.59 further emphasize its potential.
  over six months ago at Macroaxis 
By Nico Santiago
Nico Santiago
Newell Brands, a prominent player in the Consumer Defensive sector, specifically the Household Durables category, is currently undervalued with a current valuation of $9.82B. Despite a loss in retained earnings of $2.3B and a high probability of bankruptcy at 43.13%, the company's price to earnings ratio stands at a modest 9.53X, indicating potential for growth. With a net invested capital of $8.9B and a gross profit of $2.9B, the company's financial health remains robust.
  over six months ago at Macroaxis 
By Gabriel Shpitalnik
Gabriel Shpitalnik
Canaan Inc, a prominent player in the Technology sector and the Computer Hardware industry, is currently under our radar for its potential investment opportunities. As of September 2023, the company, traded on NASDAQ, boasts a robust net income from continuing operations of 658.2M, with an operating income of 557.8M. Despite a loss in free cash flow amounting to 259.7M and a depreciation and amortization loss of 214.6M, the company maintains a healthy current asset base of 984.82M.
  over six months ago at Macroaxis 
By Vlad Skutelnik
Vlad Skutelnik
Bluejay Diagnostics (USA Stocks: BJDX), a player in the Health Care Equipment & Supplies sector and part of the broader Medical Devices industry, is currently under the microscope as investors question its market valuation. With a total revenue of just $249K and a significant net income loss of $9.3M, the company's financial health is under scrutiny. Despite having a cash reserve of $10.1M and total current assets valued at $11.8M, Bluejay's enterprise value stands at a staggering $153.9M, leading to a price to sales ratio of 34.80X.
  over six months ago at Macroaxis 
By Aina Ster
Aina Ster
Revolution Medicines (NASDAQ: RVMD), a key player in the Healthcare and Biotechnology sector, has seen its stock surge over 4%, defying a modest market downturn. Despite reporting a net income loss of $248.7M and an operating income loss of $258.3M for the fiscal year ending in December, the company's stock has remained resilient. This is largely due to its strong financial position, with a working capital of $598.2M and cash and short-term investments totaling $644.9M.
  over six months ago at Macroaxis 
By Ellen Johnson
Ellen Johnson
Symbotic (USA Stocks: SYM), a key player in the Specialty Industrial Machinery industry, is currently facing a challenging financial landscape. The company reported a net income loss of $6.9M, with operating income showing a loss of $140.4M. Despite these losses, the company has managed to maintain a healthy cash position with cash and short-term investments amounting to $353.5M.
  over six months ago at Macroaxis 
By Aina Ster
Aina Ster